Regarding BCR/ABL-negative MPN, it has been shown that JAK2 signaling in these diseases leads to chromatin changes that promote NF-κB-induced inflammation and bone marrow fibrosis in MPN models. Here, JAK2 is linked to myeloproliferative disorder.